Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

363 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patient Involvement in the Design of a Phase III Trial Comparing Intensity-modulated Proton Therapy and Intensity-modulated Radiotherapy for Oropharyngeal Cancer.
Hague C, Foran B, Hall E, Guild S, Joseph O, Moule R, Nutting C, Parsons S, Prestwich R, Slevin N, West C, Thomson D. Hague C, et al. Among authors: nutting c. Clin Oncol (R Coll Radiol). 2018 May;30(5):274-276. doi: 10.1016/j.clon.2018.01.018. Epub 2018 Feb 17. Clin Oncol (R Coll Radiol). 2018. PMID: 29459100 No abstract available.
Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelines.
Guerrero Urbano MT, Clark CH, Kong C, Miles E, Dearnaley DP, Harrington KJ, Nutting CM, PARSPORT Trial Management Group. Guerrero Urbano MT, et al. Among authors: nutting cm. Clin Oncol (R Coll Radiol). 2007 Oct;19(8):604-13. doi: 10.1016/j.clon.2007.07.001. Epub 2007 Aug 13. Clin Oncol (R Coll Radiol). 2007. PMID: 17706404 Clinical Trial.
Intensity-modulated radiotherapy allows escalation of the radiation dose to the pelvic lymph nodes in patients with locally advanced prostate cancer: preliminary results of a phase I dose escalation study.
Guerrero Urbano T, Khoo V, Staffurth J, Norman A, Buffa F, Jackson A, Adams E, Hansen V, Clark C, Miles E, McNair H, Nutting C, Parker C, Eeles R, Huddart R, Horwich A, Dearnaley DP. Guerrero Urbano T, et al. Among authors: nutting c. Clin Oncol (R Coll Radiol). 2010 Apr;22(3):236-44. doi: 10.1016/j.clon.2010.01.005. Epub 2010 Feb 19. Clin Oncol (R Coll Radiol). 2010. PMID: 20171852 Clinical Trial.
External beam radiotherapy for differentiated thyroid cancer.
Powell C, Newbold K, Harrington KJ, Bhide SA, Nutting CM. Powell C, et al. Among authors: nutting cm. Clin Oncol (R Coll Radiol). 2010 Aug;22(6):456-63. doi: 10.1016/j.clon.2010.03.012. Epub 2010 Apr 27. Clin Oncol (R Coll Radiol). 2010. PMID: 20427166 Review.
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.
Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, Miles EA, Miah AB, Newbold K, Tanay M, Adab F, Jefferies SJ, Scrase C, Yap BK, A'Hern RP, Sydenham MA, Emson M, Hall E; PARSPORT trial management group. Nutting CM, et al. Lancet Oncol. 2011 Feb;12(2):127-36. doi: 10.1016/S1470-2045(10)70290-4. Epub 2011 Jan 12. Lancet Oncol. 2011. PMID: 21236730 Free PMC article. Clinical Trial.
363 results